Bikam Pharmaceuticals
ClosedCambridge, United States · Founded 2007 · $11.0M raised
- Headquarters
- Cambridge
- Employees
- 11–50
- Founded
- 2007
- Business Model
- B2B
- Total Funding
- $11.0M
- Last Round
- $11.0M Series AJan 2020
- Rounds
- 1
About
Bikam Pharmaceuticals was a biopharmaceutical company that discovered and developed small-molecule pharmacological chaperones for misfolded proteins in the retina, targeting degenerative eye diseases including retinitis pigmentosa and dry age-related macular degeneration. Its lead compound was an orally active chaperone that bound misfolded rod opsin, correcting its trafficking to the photoreceptor cell surface and outer segment. Shire acquired Bikam in July 2014 for $2.5M upfront plus up to $92M in milestone payments.
Summary
Bikam Pharmaceuticals is a Biotech company based in Cambridge, United States, founded in 2007. It has raised $11.0M in total across 1 round, most recently a $11.0M Series A round in Jan 2020. Investors include CHL Medical Partners, HealthCare and F-Prime Capital.
Funding History
Jan 2020
Sign up to see all 2 rounds
Acquisition through Series A — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/bikam-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/bikam-pharmaceuticals" alt="Bikam Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>